Restoration of the normal squamous lining in barrett's esophagus by argon beam plasma coagulation

American Journal of Gastroenterology

Volumn 93, Issue 10, 1998, Pages 1810-1815

  Byrne, James P ^a   Armstrong, Gordon R ^a   Attwood, Stephen E A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADENOCARCINOMA; ADULT; AGED; ANTIREFLUX OPERATION; ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; ESOPHAGUS CARCINOMA; ESOPHAGUS PERFORATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL PERFORATION; ESOPHAGUS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; HUMANS; LASER COAGULATION; MALE; METAPLASIA; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; TIME FACTORS;

EID: 0032417995     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.525_b.x     Document Type: Article

References (25)

1. 1. Attwood SE, Barlow AP, Norris TL, Watson A. Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complications. Br J Surg 1992;79:1050-3.
2. 2. Williamson WA, Ellis FHJ, Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151:2212-6.
3. 3. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5.
4. 4. Iftikhar SY, James PD, Steele RJ, et al. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma. GUT 1992;33:1155-8.
5. 5. Peters JH, Clark GW, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-21.
6. 6. Paraf F, Flejou J-F, Pignon J-P, et al. Surgical pathology of adenocarcinoma arising in Barrett's oesophagus: Analysis of 67 cases. Am J Surg Pathol 1995;19:183-91.
7. 7. Menke Pluymers MB, Schoute NW, Mulder AH, et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. GUT 1992;33:1454-8.
8. 8. Streitz JM, Jr, Ellis FH, Jr, Gibb SP, et al. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991;213: 122-5.
9. 9. Lerut T, Coosemans W, Van Raemdonck D. Surgical treatment of Barrett's carcinoma. J Thorac Cardiovasc Surg 1994;107:1059-66.
10. 10. Lieberman MD, Shriver CD, Bleckner S, Burt M. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg 1995;109:130-8.
11. 11. Fitzgerald RC, Omary MB, Triadafilopoulos G. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 1996;98:2120-8.
12. 12. Gillen P, Keeling P, Byrne PJ, et al. Experimental columnar metaplasia in the canine oesophagus. Br J Surg 1988;75:113-5.
13. 13. Clark GW, Smyrk TC, Mirvish SS, et al. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: An experimental rat model. Ann Surg Oncol 1994;1: 252-61.
14. 14. Sagar PM, Ackroyd R, Hosie KB, et al. Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg 1995;82:806-10.
15. 15. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994;89:1844-8.
16. 16. Gore S, Healey CJ, Sutton R, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
17. 17. Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS. Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993;38:365-8.
18. 18. Berenson MM, Johnson TD, Markowitz NR, et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993;104:1686-91.
19. 19. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus: Clinical update. Am J Gastroenterol 1996;91:1719-23.
20. 20. Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results. Gastrointest Endosc 1996;44:532-5.
21. 21. Grund K, Storek D, Farin G. Endoscopic Argon Beam Plasma Coagulation (APC): First clinical experiences in endoscopy. End Surg 1994;1:42-6.
22. 22. Grund K, Zindel C, Storek D. Endoskopische Therapie von Stenosen im Gastrointestinaltrakt. Chir Gastroenterol 1996;12:120-8.
23. 23. Sessler M, Becker H-D, Flesch I, Grund K. Therapeutic effect of Argon Plasma Coagulation on small malignant gastrointestinal tumours. J Cancer Res Clin Oncol 1995;121:235-8.
24. 24. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994;89:989-91.
25. 25. Luman W, Lessels AM, Palmer KR. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus - a pilot study. Eur J Gastroenterol Hepatol 1996;8:627-30.